Resources


Here are links to various resources and news items related to Praedicare and the hollow fiber system.

PubMed link to list of publications by our Co-Founder & Lead Scientist, Dr. Tawanda Gumbo:

https://www.ncbi.nlm.nih.gov/pubmed?term=Gumbo%2C%20Tawanda%5BAuthor%5D

The European Medicines Agency and the US FDA support the use of the hollow fiber system in the development of drugs to treat and prevent tuberculosis.

https://www.ema.europa.eu/documents/regulatory-procedural-guideline/qualification-opinion-vitro-hollow-fibre-system-model-tuberculosis-hfs-tb_en.pdf

Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool

https://academic.oup.com/cid/article/61/suppl_1/S5/348991

The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens

https://academic.oup.com/cid/article/61/suppl_1/S32/349298